Avingtrans completes minority £2.5m investment in emerging medtech leader, Adaptix

Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced its £2.5m participation in a £12.9m fund raise by emerging medtech leader, Adaptix Ltd, based in Oxford, UK.

Adaptix’s focus is on transforming radiology, by allowing low-cost, low-dose 3D portable imaging.  It has developed a number of novel technologies and imaging approaches in relation to Digital Tomosynthesis.  At the core of Adaptix’s technology is the ‘Flat Panel X-ray Source’ which consists of a monoblock containing an array of individually controlled X-ray emitters combined with a high-voltage power supply.

In its latest round of funding, Adaptix is raising up to a total of £12.9m of new funds, including £2.5m in cash from Avingtrans.  In return for the investment, Avingtrans will own approximately 5.9% of the total issued share capital of Adaptix, post the closing of the fund raise.

Avingtrans, through its majority owned-subsidiary Magnetica (“MNA”), intends to collaborate with Adaptix, to develop a disruptive business offering.  This offering will bring together low-cost 3D imaging in the form of MNA’s Cryogen-free MRI and Adaptix’s DT, to allow fusing of the image data, giving enhanced low-cost diagnostic capability, initially for orthopaedic imaging.  The target markets include some 28,000 US sites focused on minor injuries (urgent care) and private orthopaedic practices (private practices and ambulatory surgical centres). 

The purpose of the collaboration is  to create a broader offering to customers than is delivered by each business alone and ultimately to bring together low-cost 3D MRI, X-ray and potentially ultrasound, in a solution which can address a significant proportion of all medical and veterinary imaging procedures.

In the year to 31 March 2020, Adaptix made a loss after tax of £0.8m.

Mark Evans, CEO of Adaptix, said: “Our vision is to offer multi-modal 3D imaging to under-served medical markets in major economies focused on extremity imaging, which will be driven by a ‘Pay-per-Study’ business model.  Our competitive advantage will be facilitated by: the low cost of the equipment, protected and enabled by proprietary technology; equipment that does not need high-cost rooms and installation; and portability that enables equipment to be cheaply redeployed and therefore, facilitates new service models. We believe that by working with Avingtrans and Magnetica, we will be able to deliver a unique proposition to the medical imaging market.”     

Steve McQuillan, CEO of Avingtrans, commented: “We are excited by the prospect of Magnetica working with the team at Adaptix, to our mutual benefit.  As fellow travellers on parallel disruptive medical imaging paths, we believe that working together will deliver cost and market synergies for both businesses to enhance potential shareholder value, through better quality and flexible multi-modal imaging, enhancing the end customer experience.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    Avingtrans

    More articles like this

    Avingtrans

    Avingtrans announces 30.4% revenue growth in interim results

    Avingtrans PLC (LON:AVG), the international engineering group which designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial sectors, has announced its interim results for the six months ended 30

    Avingtrans

    Avingtrans Plc’s Brisbane Magnetica Ltd Appoints US Distributor

    Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that its subsidiary, Magnetica Limited, has signed a new strategic partnership with Televere

    Avingtrans

    Avingtrans plc Employee & PDMR Share Incentive Awards

    Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that on 21 November 2023, the Board of Avingtrans, in accordance with the

    Avingtrans

    Avingtrans Plc subsidiary, Hayward Tyler contract win

    Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that its U.S.-based subsidiary, Hayward Tyler Inc., has been awarded a contract by TerraPower for

    Avingtrans

    Avingtrans Plc secure two national contracts to make safe nuclear waste

    Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that Stainless Metalcraft (Metalcraft), part of the Group’s Energy and Medical division, has secured two

    Avingtrans

    Avingtrans CEO & CFO on beating market expectations (LON:AVG)

    Avingtrans Steve McQuillan & Steve King discuss the financial highlights from their preliminary results, how the divisions are performing, potentially significant market opportunities in the medical market, the acquisition of Slack and Parr and Adaptix, £13 million in the bank and what investors can expect for the rest of the year in this exclusive interview with DirectorsTalk.

    Avingtrans

    Avingtrans Plc report a robust set of results

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced its preliminary results for the year ended 31 May 2023. Financial Highlights ·      Revenue

    Avingtrans

    Avingtrans completes acquisition of Adaptix Ltd

    Avingtrans plc (LON:AVG) has announced that, further to its announcement on 13 July 2023 and following approval under the UK National Security & Investment Act, it has completed the acquisition of the remaining issued and to be

    Avingtrans

    Avingtrans’ Hayward Tyler acquires Slack & Parr

    Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that its subsidiary Hayward Tyler Fluid Handling Limited has completed the acquisition of

    Avingtrans

    Avingtrans to acquire remaining capital in Adaptix

    Avingtrans plc (LON:AVG), the engineering technology group, has announced a trading update in respect of the financial year ended 31 May 2023. The Board is pleased to report that the results for the year ended 31 May 2023 are

    Avingtrans

    Avingtrans looking to strengthen the portfolio further (LON:AVG)

    Avingtrans’ Steve McQuillan discusses interim results, the performance of the main divisions, their medical division, stronger than average order book and what investors can expect in the coming year from the company in this exclusive interview with DirectorsTalk.

    Avingtrans

    Avingtrans appoints Willem Baralt as its new Chairman

    Avingtrans PLC (LON:AVG) has announced that further to the statement made on 14 December 2022, Adaptix, the Oxford based emerging MedTech Company, has appointed Willem Baralt as its new Chairman. Willem, previously of Quanta Dialysis Technologies,

    Avingtrans

    Avingtrans investee Adaptix receives 10(k) clearance from FDA

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that medical imaging technology associate company Adaptix Limited (Adaptix) has received 510(k) clearance from